Search results for "Hepatocellular carcinoma"
Serum ferritin values may improve risk stratification of MASLD patients
Baseline hyperferritinemia occurred in almost one-third of study patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and was associated with higher stages of fibrosis.
https://gastroenterology.acponline.org/archives/2024/01/26/3.htm
26 Jan 2024
Case series describes pouchitis after immune checkpoint inhibitors
Two unusual cases of pouchitis occurred in older men receiving therapy for esophageal squamous cell carcinoma and hepatocellular carcinoma.
https://gastroenterology.acponline.org/archives/2023/08/25/11.htm
25 Aug 2023
Clinical practice update offers recommendations on noninvasive testing for NAFLD
Noninvasive tests have the potential to significantly enhance the care of patients with nonalcoholic fatty liver disease (NAFLD) by improving detection of advanced fibrosis, according to the American Gastroenterological Association.
https://gastroenterology.acponline.org/archives/2023/08/25/1.htm
25 Aug 2023
Noninvasive methods as good as biopsy for NAFLD prognosis, meta-analysis finds
An analysis of patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD) compared the prognostic value of liver stiffness measured by vibration-controlled transient elastography, fibrosis-4 index, and NAFLD fibrosis score.
https://gastroenterology.acponline.org/archives/2023/06/23/1.htm
23 Jun 2023
Spotlight on statins and chronic liver disease
Recent studies found associations between statin use and decreased risks of severe liver disease and mortality in patients with chronic liver disease.
https://gastroenterology.acponline.org/archives/2023/05/26/5.htm
26 May 2023
Case reports published on gastroenterology, hepatology topics
Reports on hepatocellular carcinoma at initial cirrhosis diagnosis, asymptomatic celiac disease, and massive splenomegaly were published in the past month.
https://gastroenterology.acponline.org/archives/2023/02/24/12.htm
24 Feb 2023
New guidance on diagnosis, management of acute hepatic porphyrias
These genetic errors of heme metabolism, although rare, appear to be more common than previously thought, and recent treatment advances have improved the outlook for patients with the diagnoses, according to the American Gastroenterological Association.
https://gastroenterology.acponline.org/archives/2023/01/27/1.htm
27 Jan 2023
Aspirin use is associated with reduced risk for hepatocellular carcinoma
The findings of a recent meta-analysis provide support for an association between aspirin use and reduced risk for hepatocellular carcinoma but do not warrant use of aspirin as prophylaxis, and more research is needed, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2022/07/22/8.htm
22 Jul 2022
U.S. sees decrease in HCC disease burden
Incidence of hepatocellular carcinoma (HCC) decreased sharply by 2.3% annually after 2011, while incidence-based mortality saw a 3.2% annual decrease after 2013, according to a study based on national data.
https://gastroenterology.acponline.org/archives/2022/02/25/2.htm
25 Feb 2022
MKSAP Quiz: Hepatocellular carcinoma surveillance after HCV treatment
This month's quiz asks readers to determine the most appropriate biannual surveillance modality for a 62-year-old patient with compensated cirrhosis who was treated for hepatitis C virus (HCV) infection six months ago.
https://gastroenterology.acponline.org/archives/2021/10/22/4.htm
22 Oct 2021